PENN CAPITAL MANAGEMENT COMPANY, LLC – Halozyme Therapeutics, Inc. Transaction History
PENN CAPITAL MANAGEMENT COMPANY, LLC portfolio value:
$2.63M
portfolio value
PENN CAPITAL MANAGEMENT COMPANY, LLC quarter portfolio value change:
-10.14%
quarter
Halozyme Therapeutics, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Decrease | -78.20% | -234.47K shares | -10.55M | $39.54 | 65.35K |
| Q2 2022 | share | Increase | +33.35% | 74.97K shares | 4.85M | $44 | 299.82K |
| Q1 2022 | share | Decrease | -19.53% | -54.57K shares | -3M | $39.88 | 224.84K |
| Q4 2021 | share | Decrease | -3.78% | -10.97K shares | -475K | $40.32 | 279.42K |
| Q3 2021 | share | Increase | +4.87% | 13.48K shares | -762K | $40.68 | 290.39K |
| Q2 2021 | share | Increase | +2.97% | 7.99K shares | 1.36M | $45.41 | 276.91K |
| Q1 2021 | share | Increase | +11.42% | 27.55K shares | 902K | $41.69 | 268.91K |
| Q4 2020 | share | Decrease | -17.50% | -51.20K shares | 2.54M | $42.71 | 241.36K |
| Q3 2020 | share | Increase | +0.86% | 2.48K shares | -79K | $26.28 | 292.57K |
| Q2 2020 | share | Increase | +2.09% | 5.94K shares | 2.72M | $26.81 | 290.08K |
| Q1 2020 | share | Increase | 0.00% | 284.14K shares | 5.11M | $17.99 | 284.14K |